plumbagin has been researched along with Sarcoma 180 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Devi, PU; Naresh, RA; Udupa, N | 1 |
1 other study(ies) available for plumbagin and Sarcoma 180
Article | Year |
---|---|
Niosomal plumbagin with reduced toxicity and improved anticancer activity in BALB/C mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Capsules; Carcinoma, Ehrlich Tumor; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Carriers; Drug Screening Assays, Antitumor; Liposomes; Mice; Mice, Inbred BALB C; Naphthoquinones; Sarcoma 180; Surface-Active Agents | 1996 |